date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-17-18,"They tackled chronic cough. Now with $54.5 million, this duo is targeting Alzheimer's and more",American City Business Journals
Oct-17-18,Merck Announces Appointment of Jim Scholefield as Chief Information and Digital Officer,Business Wire
Oct-17-18,5 Blue Chip Drug Stocks Poised for Long-Term Gains,Investopedia
Oct-18-18,Jim Scholefield Leaves Nike for Top Tech and Digital Job at Merck,The Wall Street Journal
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-19-18,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Oct-19-18,2 Dow Safety Stock for Volatile Market: Portfolio Manager,Investopedia
Oct-19-18,"Top Stock Reports for UPS, Merck & BHP Billiton",Zacks
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,Why Aduro Biotech Crashed 29.5% Today,Motley Fool
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,Here's Why ImmunoGen Fell Today,Motley Fool
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,"Mercks KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival Compared to Standard of Care, as Monotherapy and in Combination with Chemotherapy, as First-Line Treatment for Patients with Recurrent or Metastatic Head and Neck Cancer",Business Wire
Oct-22-18,Merck (MRK) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-22-18,Strong Earnings Enough Reason to Stay Long JNJ Stock,InvestorPlace
Oct-24-18,Merck's Q3 Earnings Preview,Benzinga
